glp-1 medication for weight loss Comparing Ozempic, Wegovy and Other Drugs Popular GLP-1 medications may have

Laurindo LF, Barbalho SM, Guiguer EL, da Silva Soares de Souza M, de Souza GA, Fidalgo TM, et al

Vijiaratnam N, Girges C, Auld G, Chau M, Maclagan K, King A, Skene S, Chowdhury K, Hibbert S, Morris H, Limousin P, Athauda D, Carroll CB, Hu MT, Silverdale M, Duncan GW, Chaudhuri R, Lo C, Del Din S, Yarnall AJ, Rochester L, Gibson R, Dickson J, Hunter R, Libri V, Foltynie T

41 In addition to the normal endometrium, GLP1R expression is associated with endometrial cancer, a common gynecologic malignancy strongly correlated with obesity, with over half of endometrial cancer cases attributed to obesity

The effects come on faster, fade faster, and are easier to gauge without involving your digestive system

Tirzepatide, a dual GIP/GLP-1 agonist, showed up to 20.9% average weight loss in SURMOUNT-1 at 72 weeks

Semaglutide and similar GLP-1 medications have transformed weight loss outcomes for millions of people, but like all medications, they can trigger unexpected side effects